Eliem Therapeutics (ELYM) Stock Chart & Stock Price History → Your Money is Not Safe (From American Alternative) (Ad) Free ELYM Stock Alerts $3.85 -0.33 (-7.89%) (As of 04/19/2024 ET) Add Compare Share Share ChartStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial Media Eliem Therapeutics Stock Price Performance5 Day Performance-10.67%1 Month Performance+38.49%3 Month Performance+34.15%6 Month Performance+51.57%Year-To-Date Performance+42.59%1 Year Performance+19.94% Receive ELYM Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Eliem Therapeutics and its competitors with MarketBeat's FREE daily newsletter Email Address Ad American AlternativeYour Money is Not SafeBiden Deploys Phase 1 Fednow Digital Currency Discover how to legally "opt-out" of the digital dollar today. No matter what they say, it's not something that will help you. If you don't take the action steps shown below…CLICK HERE TO GET YOUR GUIDE NOW ELYM Stock Chart for Friday, April, 19, 2024 ELYM Chart by TradingView Eliem Therapeutics Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization04/19/2024$4.18$3.85-7.89%$4.44$3.68451,267 shs$106.72 million04/18/2024$4.43$4.18-5.64%$4.50$4.15208,796 shs$122.80 million04/17/2024$4.56$4.43-2.85%$4.73$4.40211,260 shs$122.80 million04/16/2024$4.75$4.56-4.00%$4.95$4.56217,705 shs$126.40 million04/15/2024$4.31$4.75+10.21%$5.18$4.33911,995 shs$131.67 million04/12/2024$4.58$4.31-5.90%$4.97$4.301.19 million shs$119.47 million Get the Latest News and Ratings for ELYM and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Eliem Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 04/11/2024$2.67$4.58+71.54%$4.75$3.9239.07 million shs$126.96 million04/10/2024$2.70$2.67-1.11%$2.88$2.6710,804 shs$74.01 million04/09/2024$2.70$2.70$2.75$2.652,484 shs$74.84 million04/08/2024$2.60$2.70+3.85%$2.74$2.604,737 shs$74.84 million04/05/2024$2.79$2.60-6.81%$2.71$2.52116,758 shs$72.07 million04/04/2024$2.86$2.79-2.45%$2.89$2.67123,482 shs$77.34 million04/03/2024$2.81$2.86+1.78%$2.91$2.70122,798 shs$79.28 million04/02/2024$2.80$2.81+0.36%$2.95$2.708,340 shs$77.47 million04/01/2024$2.74$2.80+2.19%$2.82$2.693,314 shs$77.20 million03/29/2024$2.74$2.74$2.80$2.722,767 shs$75.55 million03/28/2024$2.76$2.74-0.72%$2.80$2.722,767 shs$75.54 million03/27/2024$2.71$2.76+1.85%$2.81$2.713,570 shs$76.09 million03/26/2024$2.82$2.71-3.90%$2.86$2.711,785 shs$74.72 million03/25/2024$2.81$2.82+0.36%$2.90$2.7314,700 shs$77.75 million03/22/2024$2.73$2.81+2.93%$2.93$2.703,755 shs$77.47 million03/21/2024$2.79$2.73-2.15%$2.80$2.727,851 shs$75.27 million03/20/2024$2.78$2.79+0.36%$2.88$2.774,836 shs$76.92 million03/19/2024$2.81$2.78-1.07%$2.90$2.6728,540 shs$76.65 million03/18/2024$2.70$2.81+4.07%$2.85$2.784,595 shs$77.47 million03/15/2024$2.79$2.70-3.23%$2.73$2.602,778 shs$74.44 million03/14/2024$2.82$2.79-1.06%$2.80$2.636,444 shs$76.93 million03/13/2024$2.54$2.82+11.02%$2.85$2.6522,721 shs$77.75 million03/12/2024$2.80$2.54-9.43%$2.81$2.545,430 shs$70.03 million03/11/2024$2.73$2.80+2.73%$2.84$2.802,690 shs$77.32 million03/08/2024$2.85$2.73-4.21%$2.84$2.721,714 shs$75.27 million03/07/2024$2.79$2.85+2.15%$2.88$2.734,231 shs$78.57 million03/06/2024$2.82$2.79-1.06%$2.85$2.765,846 shs$76.92 million03/05/2024$2.72$2.82+3.68%$2.89$2.7210,832 shs$77.76 million03/04/2024$2.69$2.72+1.12%$2.87$2.7211,280 shs$74.99 million03/01/2024$2.73$2.69-1.47%$2.75$2.67483 shs$74.16 million02/29/2024$2.65$2.73+3.02%$2.73$2.669,341 shs$75.27 million02/28/2024$2.75$2.65-3.63%$2.74$2.6549 shs$73.06 million02/27/2024$2.64$2.75+4.16%$2.83$2.733,722 shs$75.82 million02/26/2024$2.64$2.64$2.86$2.642,836 shs$72.79 millionSecret Bull Market Starts in This Unusual Sector (Ad)"We're only at the very beginning of a new wave that could deliver 500%-plus gains in the years to come." In fact, 50 small companies related to this sector have already soared 100% or more in a recent 90-day stretch. Click for my No. 1 investment, all free of charge, click here. 02/23/2024$2.63$2.64+0.38%$2.78$2.642,313 shs$72.79 million02/22/2024$2.74$2.63-4.01%$2.77$2.62789 shs$72.51 million02/21/2024$2.62$2.74+4.58%$2.74$2.6517,684 shs$75.54 million02/20/2024$2.61$2.62+0.38%$2.70$2.613,034 shs$72.24 million02/19/2024$2.61$2.61-0.06%$2.62$2.601,100 shs$71.96 million02/16/2024$2.65$2.61-1.51%$2.62$2.601,111 shs$71.96 million02/15/2024$2.66$2.65-0.38%$2.66$2.605,510 shs$73.07 million02/14/2024$2.60$2.66+2.31%$2.66$2.574,228 shs$73.34 million02/13/2024$2.60$2.60$2.74$2.604,650 shs$71.68 million02/12/2024$2.67$2.60-2.62%$2.72$2.602,183 shs$71.68 million02/09/2024$2.62$2.67+1.91%$2.67$2.606,508 shs$73.61 million02/08/2024$2.70$2.62-2.96%$2.72$2.6214,993 shs$72.23 million02/07/2024$2.65$2.70+1.88%$2.81$2.6215,695 shs$74.44 million02/06/2024$2.80$2.65-5.35%$2.77$2.6514,183 shs$73.06 million02/05/2024$2.65$2.80+5.66%$2.80$2.6919 shs$77.20 million02/02/2024$2.56$2.65+3.52%$2.65$2.65270 shs$73.06 million02/01/2024$2.56$2.56$2.56$2.56328 shs$70.58 million01/31/2024$2.73$2.56-6.23%$2.73$2.5610,658 shs$70.59 million01/30/2024$2.88$2.73-5.04%$2.76$2.73926 shs$75.27 million01/29/2024$2.88$2.88$2.88$2.8851 shs$79.26 million01/26/2024$2.90$2.88-0.69%$2.90$2.753,626 shs$79.41 million01/25/2024$2.96$2.90-2.03%$2.90$2.90349 shs$79.95 million01/24/2024$2.95$2.96+0.34%$2.96$2.88296 shs$81.61 million01/23/2024$2.88$2.95+2.43%$2.95$2.882,508 shs$81.33 million01/22/2024$2.88$2.88$2.98$2.883,144 shs$79.40 million01/19/2024$2.97$2.87-3.37%$2.88$2.87839 shs$79.13 million01/18/2024$2.94$2.97+1.02%$2.97$2.861,099 shs$81.88 million Related Companies: Karyopharm Therapeutics Stock Price Chart CytomX Therapeutics Stock Price Chart Vistagen Therapeutics Stock Price Chart FibroGen Stock Price Chart Nuvectis Pharma Stock Price Chart Repare Therapeutics Stock Price Chart OptiNose Stock Price Chart Sagimet Biosciences Stock Price Chart Citius Pharmaceuticals Stock Price Chart Coya Therapeutics Stock Price Chart Receive ELYM Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Eliem Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:ELYM) was last updated on 4/19/2024 by MarketBeat.com Staff From Our PartnersBiden’s $374B Giveaway Into This SectorDTISHOCKING Crypto Leak…Crypto 101 MediaThe #1 Crypto for 2024InvestorPlaceDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsUrgent alert: open this for a huge profit potentialTimothy SykesTiny Biotech Stock Wins $75 Billion PatentBehind the MarketsHow Biden has already won 2024Porter & CompanyTop 5 AI Stocks to Buy for 2024Market Moving Trends Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Eliem Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.